We are live on ! Find out more
ABEOW

Abeona Therapeutics Inc Warrant
ABEOW

Delisted

ABEOW was delisted on the 20th of December, 2019.

Back to rankings

2 hedge funds and large institutions have $5.14M invested in Abeona Therapeutics Inc Warrant in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $4.42M → $5.14M (+$713K)

0% more funds holding

Funds holding: 2 → 2 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$4.29M – – –
SFM
2
Soros Fund Management
New York
$851K – – –

ABEOW Hedge Fund Activity: Q2 2017 in Review

2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q2 2017, worth a combined $5.14M — up 16% from $4.42M a quarter earlier.

Fund positioning in ABEOW was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $5.14M of Abeona Therapeutics Inc Warrant stock for Q2 2017, up 16% quarter-over-quarter.
  • 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q2 2017 and 0 closed out.

Based on aggregated 13F filings for Q2 2017.